Literature DB >> 433973

Treatment of Goodpasture's syndrome with plasmapheresis. A case report and review of the literature.

S G Rosenblatt, W Knight, G A Bannayan, C B Wilson, J H Stein.   

Abstract

A case is reported of antiglomerular basement membrane antibody-induced Goodpasture's syndrome in which the patient required hemodialysis and was treated with immunosuppressive agents and plasmapheresis. A severe (80 per cent) cresentic lesion was reversed, and creatinine was stabilized at 2.5 mg/dl at one year follow-up. Earlier reports of therapy without plasmapheresis showed that 88 per cent of the patients would either die or require long-term hemodialysis. Fifteen other reported cases of Goodpasture's syndrome in which the patients were treated with plasmapheresis are reviewed. When reported, short-term follow-up showed that nine of these patients were alive without need of dialysis, five wee receiving dialysis, and only two had died. This suggests that plasmaheresis and immunosuppressive therapy may reverse the renal lesion in some patients with Goodpasture's syndrome.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 433973     DOI: 10.1016/0002-9343(79)91186-0

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  4 in total

Review 1.  Small vessel vasculitis of the lung.

Authors:  M I Schwarz; K K Brown
Journal:  Thorax       Date:  2000-06       Impact factor: 9.139

2.  Long-term clinical course in acute crescentic glomerulonephritis.

Authors:  D Bach; K Hauser; B Grabensee
Journal:  Int Urol Nephrol       Date:  1996       Impact factor: 2.370

3.  Goodpasture's syndrome: treatment with plasmapheresis, immunosuppression, and anticoagulation.

Authors:  M Levin; S P Rigden; J R Pincott; C M Lockwood; T M Barratt; M J Dillon
Journal:  Arch Dis Child       Date:  1983-09       Impact factor: 3.791

Review 4.  Pulmonary renal syndromes. II. Etiology and pathogenesis.

Authors:  J A Rankin; R A Matthay
Journal:  Yale J Biol Med       Date:  1982 Jan-Feb
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.